DARZALEX 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Janssen-Cilag International N.V🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 57f8d1114acd29a2
Drug Cima Aemps Name: DARZALEX 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1161101002IP1
Holder Company Name: Janssen-Cilag International N.V
Marketing Company Name: Orifarm A/S
Holder Company Detail Path: /organization/janssen-cilag-international-nv
Authorization Date: 2025-09-16
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 20 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Janssen-Cilag International N.V
Company Detail Path: /organization/janssen-cilag-international-nv

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 16, 2025

Approval ID

57f8d1114acd29a2

Type

Standard